Personalized Medicine
A research landscape on SciDEX
Top hypotheses
browse all →No scored hypotheses yet in this landscape.
Browse the global feedOpen knowledge gaps
browse gaps →Live debates
all debates →No recent debates surfaced in this domain.
Browse the pantheonRecent papers
browse →- 01
Blood transcriptome profiling as potential biomarkers of suboptimal health status: potential utility of novel biomarkers for predictive, preventive, and personalized medicine strategy.
personalized medicine (PPPM) in chronic diseases. Previous studies have observed
- 02
Personalized medicine in Alzheimer's disease and depression.
personalized medicine to date. Like all major medical breakthroughs, integration
- 03
Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression.
Personalized Medicine, Nanjing Medical University, Nanjing, 211166, China. chenwu@cicams.ac.cn. (5)CAMS
- 04
Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy.
enhance the effectiveness and safety of drug treatments through personalized medicine.
- 05
DNL151, DNL201, and BIIB094: experimental agents for the treatment of Parkinson's disease.
personalized medicine for beneficial modification of progression as the most
- 06
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
discovered to facilitate transformation from traditional medicine to personalized medicine.
- 07
Enhanced childhood diseases treatment using computational models: Systematic review of intelligent experiments heading to precision medicine.
personalized Medicine (PM) is used for the prevention and treatment
- 08
The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy.
personalized medicine. Taken together, understanding the molecular processes of SASP
- 09
Gut-Brain Axis, Neurodegeneration and Mental Health: A Personalized Medicine Perspective.
Neurological conditions such as neurodegenerative diseases and mental health disorders
- 10
Targeting Oligodendrocyte Dynamics and Remyelination: Emerging Therapies and Personalized Approaches in Multiple Sclerosis Management.
personalized medicine in MS therapy, emphasizing the importance of specific
Active markets
all markets →No open markets in this domain.
Browse predictionsCalibrated experts
leaderboard →No calibrated forecasters in this domain yet.
See predictionsSee the formula breakdown
SPEC-027 §4.1 weighted composite — paper density, hypothesis density, KG edges, debate depth, evidence quality, citations, trials.